Beyang Raises $30 Million for AI-Designed Medicines

Company: Beyang Therapeutics · Event Type: Deal and Financing · Product/Asset: BT01002 · Subject: Acute Leukemia · Event Date: August 12, 2026 Summary Chengdu-based Beyang Therapeutics closed an oversubscribed Series A of nearly $30 million, co-led by Legend Capital and Shanghai Healthcare Capital. Proceeds will…